FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agustin Garcia

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Bichlien Nguyen; Edgardo Rivera; Lisette Stork-Sloots; Jeroen van den Akker; Katharine Yao; Julie L Barone; Pino G Cusumano; Femke A De Snoo; Kenneth Deck; Agustin A Garcia; Deborah Kerlin; Daniele Generali
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients.
Nancy U Lin; David Mendelson; Pamela Munster; Martina Uttenreuther-Fischer; Richard Vinisko; Duncan Wheatley; Sven Wind; Eric P Winer; Lisa A Carey; Susan Cleator; Laurie Frakes; Agustin A Garcia; Stephen Houston; Hilary Jones; Steve Kelly; Tamas Hickish
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Agustin A Garcia; Laila I Muderspach; Huyen Pham; Grace Facio; Anne Yessaian; Lynda Roman
Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agustin Garcia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bichlien Nguyen; Edgardo Rivera; Lisette Stork-Sloots; Jeroen van den Akker; Katharine Yao; Julie L Barone; Pino G Cusumano; Femke A De Snoo; Kenneth Deck; Agustin A Garcia; Deborah Kerlin; Daniele Generali
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients.
Annals of surgical oncology 2012;19(10):3257-63.
2012: Nancy U Lin; David Mendelson; Pamela Munster; Martina Uttenreuther-Fischer; Richard Vinisko; Duncan Wheatley; Sven Wind; Eric P Winer; Lisa A Carey; Susan Cleator; Laurie Frakes; Agustin A Garcia; Stephen Houston; Hilary Jones; Steve Kelly; Tamas Hickish
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Breast cancer research and treatment 2012;133(3):1057-65.
2012: Agustin A Garcia; Laila I Muderspach; Huyen Pham; Grace Facio; Anne Yessaian; Lynda Roman
Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.
Cancer investigation 2012;30(4):295-9.
2012: Agustin A Garcia; Andrew K Godwin; Heather A Lankes; Marcia K Liepman; Robert S Mannel; Michael W Sill; Nick M Spirtos; Deborah K Armstrong; Robert L Carolla; Edgar G Fischer; Kimberly K Leslie
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study.
Gynecologic oncology 2012;124(3):569-74.
2011: Syma Iqbal; Denice D Tsao-Wei; David I Quinn; Barbara J Gitlitz; Susan Groshen; Ana Aparicio; Heinz-Josef Lenz; Anthony El-Khoueiry; Jacek Pinski; Agustin A Garcia
Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors.
American journal of clinical oncology 2011;34(1):27-31.
2010: Amy D Tiersten; Michael W Sill; Danielle Knight; Franco Muggia; Agustin A Garcia; Ron Swensen; David P Warshal; Robert S Mannel; Paula M Fracasso
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2010;118(3):303-7.
2008: Anne M Schultheis; Georg Lurje; Katrin E Rhodes; Wu Zhang; Dongyun Yang; Agustin A Garcia; Robert Morgan; David R Gandara; Sidney Scudder; Amit Oza; Hal Hirte; Gini Fleming; Lynda Roman; Heinz-Josef Lenz
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7554-63.
2008: Agustin A Garcia; John A Blessing; Susan A. Nolte; Robert S Mannel
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
Gynecologic oncology 2008;111(1):22-6.
2008: Agustin A Garcia; Hal Hirte; Gini Fleming; Dongyun Yang; Denice D Tsao-Wei; Lynda Roman; Susan Groshen; Stephen Swenson; Francis S Markland; David R Gandara; Sidney Scudder; Robert Morgan; Helen Chen; Heinz-Josef Lenz; Amit Oza
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):76-82.
2007: Shay Ashouri; Agustin A Garcia
Current status of signal transduction modulators in the treatment of gynecologic malignancies.
Current treatment options in oncology 2007;8(6):383-92.
2007: Agustin A Garcia; John A Blessing; Luis Vaccarello; Lynda D Roman
Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
American journal of clinical oncology 2007;30(4):428-31.
2007: Roy L Pañares; Agustin A Garcia
Bevacizumab in the management of solid tumors.
Expert review of anticancer therapy 2007;7(4):433-45.
2007: Agustin A Garcia; John A Blessing; Kathleen M Darcy; Heinz-Josef Lenz; Wu Zhang; Ed Hannigan; David H Moore
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Gynecologic oncology 2007;104(3):572-9.
2006: Michael S Gordon; Daniela Matei; Carol Aghajanian; Ursula Matulonis; Molly Brewer; Gini F Fleming; John D Hainsworth; Agustin A Garcia; Mark D Pegram; Russell J Schilder; David E Cohn; Lynda Roman; Mika K Derynck; Kimmie Ng; Benjamin Lyons; David E Allison; David A Eberhard; Thinh Q Pham; Randall C Dere; Beth Y Karlan
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4324-32.
2006: Richard E Gould; Agustin A Garcia
Update on aromatase inhibitors in breast cancer.
Current opinion in obstetrics & gynecology 2006;18(1):41-6.
2006: Agustin A Garcia; Syma Iqbal; David Quinn; Susan Edwards; Heinz-Josef Lenz; Jeff Weber
Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.
Investigational new drugs 2006;24(1):79-83.
2005: Agustin A Garcia; Mahesh Pujari; Susan Jeffers; Syma Iqbal; Heinz-Josef Lenz; Paul M Beringer; Stan Louie
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
Cancer chemotherapy and pharmacology 2005;56(1):75-82.
2005: Agustin A Garcia; John A Blessing; Heinz-Josef Lenz; Kathleen M Darcy; Robert S Mannel; David Scott Miller; Nader Husseinzadeh
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.
Gynecologic oncology 2005;96(3):810-7.
2005: Agustin A Garcia; Lynda Roman; Laila I Muderspach; Anne O'Meara Rodriguez; Grace Facio; Susan Edwards; Alexander Burnett
Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
Cancer investigation 2005;23(8):665-70.
2004: Agustin A Garcia; Anne O'Meara Rodriguez; Afshin Bahador; Grace Facio; Susan Jeffers; Dae-Young Kim; Lynda Roman
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
Gynecologic oncology 2004;93(2):493-8.
2003: Agustin A Garcia; Lawrence Leichman; Joaquina Baranda; Lalita Pandit; Heinz-Josef Lenz; Cynthia G Leichman
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.
International journal of gastrointestinal cancer 2003;34(2-3):79-86.
2002: Agustin A Garcia; Michael A Bookman; Lorna Rodriguez-Rodriguez; David G Mutch; Katherine Y Look
Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
Investigational new drugs 2002;20(4):383-7.
2001: Agustin A Garcia; Franco M Muggia; CP Spears; Susan Jeffers; Howard Silberman; Mahesh Pujari; Robert T Koda
Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin.
Anti-cancer drugs 2001;12(6):505-11.
2001: Agustin A Garcia; Cynthia G Leichman; Heinz-Josef Lenz; Joaquina Baranda; R Lujan; Y Casagrande; Lawrence Leichman
Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
Japanese journal of clinical oncology 2001;31(6):275-8.
2000: V P Israel; Agustin A Garcia; Lynda Roman; Laila I Muderspach; Alexander Burnett; Susan Jeffers; Franco M Muggia
Phase II study of liposomal doxorubicin in advanced gynecologic cancers.
Gynecologic oncology 2000;78(2):143-7.
2000: Alexander F Burnett; Lynda D Roman; Agustin A Garcia; Laila I Muderspach; K R Brader; C Paul Morrow
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Gynecologic oncology 2000;76(1):63-6.
1999: Agustin A Garcia
Salvage therapy for ovarian cancer.
Current oncology reports 1999;1(1):64-70.
1999: Robert T Koda; Agustin A Garcia; D J Chatterjee; Wen Yen Li; D Parimoo; Susan Jeffers; M Rogers; Cynthia G Leichman; Lawrence Leichman; Ellen Y Wu; Bhasker Shetty; S Webber; N Clendinnin; Franco M Muggia
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors.
Cancer chemotherapy and pharmacology 1999;43(6):489-96.
1998: Agustin A Garcia; S Keren-Rosenberg; D Parimoo; M Rogers; Susan Jeffers; Robert T Koda; Franco M Muggia
Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2959-63.
1997: Agustin A Garcia; D Parimoo; I Dimery; M Rogers; Susan Jeffers; Franco M Muggia
Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule.
Seminars in oncology 1997;24(6 Suppl 19):S19-62-S19-66.
1996: Agustin A Garcia; Barbara D Florentine; A J Simons; Eila C Skinner; L W Leichman
Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer. Report of a case.
Diseases of the colon and rectum 1996;39(9):1051-4.